Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

14 Sep 2012 07:00

RNS Number : 2322M
Imaginatik PLC
14 September 2012
 



14 September 2012

 

Imaginatik Plc

("Imaginatik" or the "Company")

 

AGM Statement

 

At the Company's Annual General Meeting to be held later today, Matthew Cooper, Executive Chairman of Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy, will make the following statement:

 

"We have continued to make good progress in the first half of the financial year. So far in this financial year we have contracted with 12 new customers across Europe and the US which is double that achieved in the same period of last year. We also expect to finalise a number of additional annual contracts in the short term.

 

"Importantly, we are experiencing growth in the number of contracts for strategic consultancy, including contracts with Mead Johnson, Proctor & Gamble and The Society of Petroleum Engineers. Most new annual contracts being signed now include some element of operational consulting, endorsing our strategy to offer 'full service' innovation capabilities to clients, rather than standalone software.

 

"We have been encouraged by progress in the European market, where we have recently increased our sales capacity, securing two small annual deals in the UK and Spain and a pilot with a UK headquartered global betting and gaming company. While relatively modest in size initially, each has the potential for significant expansion and we believe we are well placed to benefit further from the growing European innovation market.

 

"We have continued to invest in the development of our technology platform and have begun incorporating multi-lingual capabilities and connectors into some of the fastest growing corporate platforms, such as SharePoint, Jive and Yammer. We believe both of these initiatives will significantly increase our addressable market.

 

"The general economy stills poses a challenge, evidenced by the loss of three customers in the period due to budgetary constraints. However, each of these contracts was based on our 'old model' with no consultancy support and we are confident that as an increasing number of our customers rely on Imaginatik to provide them with full innovation capabilities, we will increase the stickiness of our customer base.

 

"Given that we have a number of new contracts pending we look forward to providing an update on our financial performance to the market following the period end."

 

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

 

About Imaginatik

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFMGMLDFGGZZM
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.